Pfizer Inc (NYSE: PFE) kicked off on Friday, up 0.83% from the previous trading day, before settling in for the closing price of $25.37. Over the past 52 weeks, PFE has traded in a range of $24.48-$31.54.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 10.96% over the last five years. While this was happening, its average annual earnings per share was recorded 58.03%. With a float of $5.67 billion, this company’s outstanding shares have now reached $5.67 billion.
The firm has a total of 88000 workers. Let’s measure their productivity. In terms of profitability, gross margin is 59.1%, operating margin of 16.85%, and the pretax margin is 6.49%.
Pfizer Inc (PFE) Breakdown of a Key Holders of the stock
Our next focus will be how large-scale investors are participating in this stock of the Drug Manufacturers – General Industry. The insider ownership of Pfizer Inc is 0.03%, while institutional ownership is 67.54%. The most recent insider transaction that took place on Oct 30 ’24, was worth 28,240. In this transaction Director of this company bought 1,000 shares at a rate of $28.24, taking the stock ownership to the 10,000 shares. Before that another transaction happened on Aug 13 ’24, when Company’s SVP & Controller sold 5,154 for $28.66, making the entire transaction worth $147,714. This insider now owns 8,582 shares in total.
Pfizer Inc (PFE) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around 58.03% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 7.55% during the next five years compared to -27.43% drop over the previous five years of trading.
Pfizer Inc (NYSE: PFE) Trading Performance Indicators
Take a look at Pfizer Inc’s (PFE) current performance indicators. Last quarter, stock had a quick ratio of 0.73. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.43. Likewise, its price to free cash flow for the trailing twelve months is 17.77.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.74, a number that is poised to hit 0.48 in the next quarter and is forecasted to reach 2.89 in one year’s time.
Technical Analysis of Pfizer Inc (PFE)
Analysing the last 5-days average volume posted by the [Pfizer Inc, PFE], we can find that recorded value of 37.61 million was lower than the volume posted last year of 38.49 million. As of the previous 9 days, the stock’s Stochastic %D was 22.36%. Additionally, its Average True Range was 0.55.
During the past 100 days, Pfizer Inc’s (PFE) raw stochastic average was set at 15.58%, which indicates a significant decrease from 37.41% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 21.63% in the past 14 days, which was lower than the 21.94% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $27.22, while its 200-day Moving Average is $27.99. Now, the first resistance to watch is $25.74. This is followed by the second major resistance level at $25.90. The third major resistance level sits at $26.14. If the price goes on to break the first support level at $25.34, it is likely to go to the next support level at $25.10. Now, if the price goes above the second support level, the third support stands at $24.94.
Pfizer Inc (NYSE: PFE) Key Stats
The company with the Market Capitalisation of 146.16 billion has total of 5,666,990K Shares Outstanding. Its annual sales at the moment are 58,496 M in contrast with the sum of 2,119 M annual income. Company’s last quarter sales were recorded 17,702 M and last quarter income was 4,465 M.
